| HoLEP | UroLift | Rezūm | |
|---|---|---|---|
| Main strategy | Remove adenoma | Retract obstructing tissue | Shrink treated tissue |
| Tissue removed | Yes | No | No surgical specimen |
| Ejaculation | Antegrade ejaculation commonly changes | Often prioritised for preservation | Often prioritised for preservation |
| Durability discussion | Anatomical tissue removal | Higher retreatment likelihood than TURP should be discussed | Retreatment and medication restart should be discussed |
Why would someone choose UroLift or Rezūm?
For appropriately selected men, faster recovery and preservation of ejaculation may be important priorities. Current European guidance recommends UroLift particularly for men interested in preserving ejaculation with prostates under 70 mL and no middle lobe; evidence for effectiveness in large glands remains limited.
Why would someone choose HoLEP?
HoLEP is a fundamentally more tissue-removing operation. It is attractive when the objective is substantial anatomical relief of obstruction and durability, including in larger glands, but it is a more technically demanding procedure and ejaculatory change is an important trade-off.
Where does Rezūm fit?
Water-vapour therapy can improve symptoms while generally preserving erectile and ejaculatory function. Current evidence also supports counselling about retreatment or restarting medication over follow-up. The improvement in objective flow measures is generally less dramatic than with tissue-removing surgery.
References & evidence
- European Association of Urology. EAU Guidelines on Non-neurogenic Male LUTS — Disease Management. 2026. See sections on HoLEP, prostatic urethral lift and water-vapour therapy.
Medical content reviewed 13 September 2026.
Procedure choice should be individual
Prostate anatomy, symptoms, bladder function, medical history, priorities regarding ejaculation, durability and the experience of the treating surgeon all matter.
Call +91 93110 98987